Extremely important negative changes in investment behavior have recently occurred for Evolent Health Inc (NYSE: EVH): the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, its longer term price trend turned down, and negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, EVH is expected to continue to be an important Value Builder.
Evolent Health has a current Value Trend Rating of C (High Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Evolent Health has a slightly negative Appreciation Score of 38 but a good Power Rating of 80, and the High Neutral Value Trend Rating results.
Recent Price Action
Evolent Health Inc (NYSE: EVH) stock declined by -2.9% on 4/24/24. The shares closed at $29.26. NORMAL trading volume accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -3.0% during the last week.
Be the first to comment